This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: Fitbit, Inc., Abbott Diabetes Care Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: **Rifat Emrah Ozel: Innovating Medical Analysis through Microfluidics**
Introduction
Rifat Emrah Ozel is an innovative inventor based in San Jose, California, recognized for his contributions to the field of microfluidics. With a total of four patents to his name, Ozel has been pivotal in advancing point-of-care diagnostic technologies, particularly in analyzing biological fluid analytes like blood.
Latest Patents
Among his latest inventions is the microfluidic metering and delivery system. This novel invention offers unique devices, systems, and methods for performing point-of-care analysis, including multiplexed analysis of biological fluid analytes. It incorporates a cartridge designed for collecting the analyte, which can be inserted into an assay reader. This reader conducts one or more assay reactions, subsequently reading and reporting the results efficiently.
Career Highlights
Rifat Emrah Ozel is currently employed at Fitbit, Inc., where he continues to push the boundaries of medical technology and healthcare innovations. His work reflects a strong commitment to enhancing diagnostic procedures and ensuring rapid analysis in medical settings.
Collaborations
Ozel collaborates with talented professionals including Junyu Mai and Albert Gutes-Regidor, demonstrating his ability to work within a team to develop groundbreaking technologies. These collaborations not only enrich his inventions but also contribute to rapid advancements in the field.
Conclusion
Rifat Emrah Ozel stands out as a prominent figure in medical technology innovation. His latest inventions, particularly in microfluidics, showcase his dedication to improving healthcare diagnostics. As he continues to collaborate with leading minds in the industry, the impact of his work is sure to benefit many in the quest for efficient medical analysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

